遺伝子組換え型ウナギ成長ホルモンの精製
スポンサーリンク
概要
- 論文の詳細を見る
A purification procedure for highly purified and highly uniform recombinant eel growth hormone (EGH) was established and found to be applicable to large-scale production. Inclusion bodies of recombinant EGH expressed in <I>Escherichia coli</I> were obtained by the disruption of cells and washing. The inclusion bodies were solubilized in urea solution and refolded by dilution and addition of oxidized glutathione. EGH analogues such as oxidized EGH at methionine and formylated EGH at <I>N</I>-terminal, which were produced during the fermentaion and/or purification process, were removed by subsequent hydrophobic interaction chromatography.
- 社団法人 化学工学会の論文
著者
関連論文
- 38.新規エチレン作用抑制化合物cis-propenyl-phos-phonic acid (第26回大会研究発表抄録)
- 38 新規エチレン作用抑制化合物cis-propenylphosphonic acid
- タンパク質誘導体新薬「ノイアップ」の開発 : 農芸化学技術賞
- 遺伝子組換え型ウナギ成長ホルモンの精製
- シスプロペニルポスホン酸によるバラ切り花の開花遅延
- 遺伝子組換え型シロザケ成長ホルモンの諸性質〔英文〕
- Study on Recombinant Granulocyte-Colony Stimulating Factor (KW-2228):Development of Enzyme-Linked Immunosorbent Assays for the Detection of Anti-KW-2228 Antibody and Anti-E. coil Protein Antibody